Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Teratocarcinoma D018243 7 associated lipids
Adenomatous Polyps D018256 4 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Hematologic Neoplasms D019337 4 associated lipids
Endotoxemia D019446 27 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Ileus D045823 3 associated lipids
Atherosclerosis D050197 85 associated lipids
Niemann-Pick Disease, Type C D052556 1 associated lipids
Lung Injury D055370 14 associated lipids
Acute Lung Injury D055371 33 associated lipids
Farber Lipogranulomatosis D055577 1 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Tani M et al. Sphingosine 1-phosphate (S1P) inhibits monocyte-endothelial cell interaction by regulating of RhoA activity. 2007 FEBS Lett. pmid:17825823
Chun J Immunology. The sources of a lipid conundrum. 2007 Science pmid:17431159
Liao JJ et al. Distinctive T cell-suppressive signals from nuclearized type 1 sphingosine 1-phosphate G protein-coupled receptors. 2007 J. Biol. Chem. pmid:17121832
Sanchez T et al. Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN. 2007 Arterioscler. Thromb. Vasc. Biol. pmid:17431187
Jang S et al. Cytochemical alterations in the rat retina by LPS administration. 2007 Neurochem. Res. pmid:17160463
Harvey KA et al. Diverse signaling pathways regulate fibroblast differentiation and transformation through Rho kinase activation. 2007 J. Cell. Physiol. pmid:17167780
Blondeau N et al. Distribution of sphingosine kinase activity and mRNA in rodent brain. 2007 J. Neurochem. pmid:17623044
Giussani P et al. Sphingosine-1-phosphate and calcium signaling in cerebellar astrocytes and differentiated granule cells. 2007 Neurochem. Res. pmid:17151916
Huwiler A and Zangemeister-Wittke U Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy. 2007 Crit. Rev. Oncol. Hematol. pmid:17560117
Pchejetski D et al. Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis. 2007 Circ. Res. pmid:17158340
Omori K et al. Edaravone mimics sphingosine-1-phosphate-induced endothelial barrier enhancement in human microvascular endothelial cells. 2007 Am. J. Physiol., Cell Physiol. pmid:17686998
Keul P et al. The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice. 2007 Arterioscler. Thromb. Vasc. Biol. pmid:17158351
Walter DH et al. Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor. 2007 Arterioscler. Thromb. Vasc. Biol. pmid:17158356
Phan VH et al. Disruption of sphingolipid metabolism elicits apoptosis-associated reproductive defects in Drosophila. 2007 Dev. Biol. pmid:17706961
Barthomeuf C Inhibition of S1P-induced angiogenesis, metastasis and inflammation by dietary polyphenols. 2007 Free Radic. Biol. Med. pmid:17189837
Currie JC et al. MT1-MMP down-regulates the glucose 6-phosphate transporter expression in marrow stromal cells: a molecular link between pro-MMP-2 activation, chemotaxis, and cell survival. 2007 J. Biol. Chem. pmid:17229722
Yang Q Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival. 2007 Cardiovasc. Res. pmid:17331485
Landeen LK et al. Sphingosine-1-phosphate receptor expression in cardiac fibroblasts is modulated by in vitro culture conditions. 2007 Am. J. Physiol. Heart Circ. Physiol. pmid:17337593
Maeda Y et al. Migration of CD4 T cells and dendritic cells toward sphingosine 1-phosphate (S1P) is mediated by different receptor subtypes: S1P regulates the functions of murine mature dendritic cells via S1P receptor type 3. 2007 J. Immunol. pmid:17339438
Serriere-Lanneau V et al. The sphingosine 1-phosphate receptor S1P2 triggers hepatic wound healing. 2007 FASEB J. pmid:17341687
Means CK et al. Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury. 2007 Am. J. Physiol. Heart Circ. Physiol. pmid:17293497
Aoki S et al. The suppressive effect of sphingosine 1-phosphate on monocyte-endothelium adhesion may be mediated by the rearrangement of the endothelial integrins alpha(5)beta(1) and alpha(v)beta(3). 2007 J. Thromb. Haemost. pmid:17403093
Novgorodov AS et al. Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration. 2007 FASEB J. pmid:17255471
Masuko K et al. Sphingosine-1-phosphate attenuates proteoglycan aggrecan expression via production of prostaglandin E2 from human articular chondrocytes. 2007 BMC Musculoskelet Disord pmid:17374154
Young N and Van Brocklyn JR Roles of sphingosine-1-phosphate (S1P) receptors in malignant behavior of glioma cells. Differential effects of S1P2 on cell migration and invasiveness. 2007 Exp. Cell Res. pmid:17376432
Sato K et al. Critical role of ABCA1 transporter in sphingosine 1-phosphate release from astrocytes. 2007 J. Neurochem. pmid:17931360
Morales A et al. Pharmacological inhibition or small interfering RNA targeting acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo. 2007 Oncogene pmid:16862171
Cai Q et al. Validation of fumonisin biomarkers in F344 rats. 2007 Toxicol. Appl. Pharmacol. pmid:17904604
Dyatlovitskaya EV The role of lysosphingolipids in the regulation of biological processes. 2007 Biochemistry Mosc. pmid:17573701
Anada Y et al. The immunomodulator FTY720 is phosphorylated and released from platelets. 2007 Eur. J. Pharmacol. pmid:17553484
Gandolfo MT and Rabb H Very early alloantigen-independent trafficking of lymphocytes during ischemic acute kidney injury. 2007 Kidney Int. pmid:17554348
Keul P et al. HDL and its sphingosine-1-phosphate content in cardioprotection. 2007 Heart Fail Rev pmid:17554629
Langlois S et al. Membrane-type 1 matrix metalloproteinase stimulates cell migration through epidermal growth factor receptor transactivation. 2007 Mol. Cancer Res. pmid:17541067
Sato K et al. HDL-like lipoproteins in cerebrospinal fluid affect neural cell activity through lipoprotein-associated sphingosine 1-phosphate. 2007 Biochem. Biophys. Res. Commun. pmid:17544365
Levine YC et al. Agonist-modulated regulation of AMP-activated protein kinase (AMPK) in endothelial cells. Evidence for an AMPK -> Rac1 -> Akt -> endothelial nitric-oxide synthase pathway. 2007 J. Biol. Chem. pmid:17519230
Kimura T et al. [Measurement of sphingosine 1-phosphate as a biomarker of atherosclerosis]. 2007 Rinsho Byori pmid:17511266
Aoki S et al. Fluid shear stress enhances the sphingosine 1-phosphate responses in cell-cell interactions between platelets and endothelial cells. 2007 Biochem. Biophys. Res. Commun. pmid:17512899
Huang MC et al. Th17 augmentation in OTII TCR plus T cell-selective type 1 sphingosine 1-phosphate receptor double transgenic mice. 2007 J. Immunol. pmid:17513728
Iwaki S et al. Intracellular trafficking pathway of yeast long-chain base kinase Lcb4, from its synthesis to its degradation. 2007 J. Biol. Chem. pmid:17686782
Kim K et al. Sphingosine 1-phosphate (S1P) induces shape change in rat C6 glioma cells through the S1P2 receptor: development of an agonist for S1P receptors. 2007 J. Pharm. Pharmacol. pmid:17637200
Kurashima Y et al. Sphingosine 1-phosphate-mediated trafficking of pathogenic Th2 and mast cells for the control of food allergy. 2007 J. Immunol. pmid:17641024
Kawanabe T et al. Sphingosine 1-phosphate accelerates wound healing in diabetic mice. 2007 J. Dermatol. Sci. pmid:17643267
Brizuela L et al. Sphingosine-1-phosphate stimulates aldosterone secretion through a mechanism involving the PI3K/PKB and MEK/ERK 1/2 pathways. 2007 J. Lipid Res. pmid:17609523
Jin ZQ et al. A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia/reperfusion injury. 2007 Cardiovasc. Res. pmid:17610857
Karahatay S et al. Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C(18)-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis. 2007 Cancer Lett. pmid:17619081
Murph M and Mills GB Targeting the lipids LPA and S1P and their signalling pathways to inhibit tumour progression. 2007 Expert Rev Mol Med pmid:17935635
Oskeritzian CA et al. Sphingosine-1-phosphate in allergic responses, asthma and anaphylaxis. 2007 Pharmacol. Ther. pmid:17669501
Xu M et al. Sphingosine 1-phosphate rapidly increases endothelial barrier function independently of VE-cadherin but requires cell spreading and Rho kinase. 2007 Am. J. Physiol., Cell Physiol. pmid:17670896
Zhu HY and Da WM [Regulation of immunity by sphingosine 1-phosphate and its G protein-coupled receptors--review]. 2007 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:18088493
Igarashi J et al. Hydrogen peroxide induces S1P1 receptors and sensitizes vascular endothelial cells to sphingosine 1-phosphate, a platelet-derived lipid mediator. 2007 Am. J. Physiol., Cell Physiol. pmid:16943246